76 patents currently held
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
The next term ends in Apr 2030. from the record
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
15
Ending by 2030
Apr 2030
Next term end
8
Patent families
When these terms end
Held patents by the year their term ends
notable patents
all others
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Notable: the highest-ranked patents in this portfolio by citations and family size.
Notable patents
Ranked by citations and family size, against patents of the same kind granted the same year. How we rank
Notable
Ends Apr 2031 · High confidence
Also notable
Ends Jun 2034 · High confidence
Also notable
Ends Aug 2030 · High confidence
Also notable
Ends Mar 2034 · High confidence
Also notable
Ends Jun 2034 · High confidence
Also notable
Ends Oct 2031 · High confidence
Also notable
Ends Nov 2034 · High confidence
Also notable
Ends Sep 2032 · High confidence
System for Analyzing Targets of a Tissue Section
US 11,542,543
Cited by 188 later US patents, top 1% of utility patents granted in 2023 in our data. Protection runs to 2031. A terminal disclaimer caps this term to an earlier patent's.
Methods and Systems for Determining Spatial Patterns of Biological Targets in a Sample
US 11,286,515
Cited by 259 later US patents, top 1% of utility patents granted in 2022 in our data. Protection runs to 2034. A terminal disclaimer caps this term to an earlier patent's.
Nucleic Acid Constructs and Methods of Use
US 9,085,798
The most cited patent in this portfolio, cited by 771 later US patents, top 1% of utility patents granted in 2015 in our data. Protection runs to 2030.
Methods for Detecting Peptide/Mhc/Tcr Binding
US 11,231,419
Cited by 80 later US patents, top 1% of utility patents granted in 2022 in our data. Protection runs to 2034. A terminal disclaimer caps this term to an earlier patent's.
Spatially Encoded Biological Assays Using a Microfluidic Device
US 9,868,979
Cited by 462 later US patents, top 1% of utility patents granted in 2018 in our data, and renewed at every maintenance window due so far. Protection runs to 2034.
Methods for Manufacturing Molecular Arrays
US 8,987,174
Cited by 143 later US patents, top 5% of utility patents granted in 2015 in our data, and renewed at 3 of 3 maintenance windows. Protection runs to 2031.
Polynucleotide Conjugates and Methods for Analyte Detection
US 10,288,608
Cited by 69 later US patents, top 5% of utility patents granted in 2019 in our data, and renewed at 2 of 3 maintenance windows. Protection runs to 2034.
Peptide Constructs and Assay Systems
US 9,958,454
Cited by 42 later US patents, top 10% of utility patents granted in 2018 in our data, and renewed at every maintenance window due so far. Protection runs to 2032.
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 1 fee due Jan 21, 2027The maintenance fee for Nucleic Acid Constructs and Methods of Use (US 9,085,798) comes due Jan 21, 2027. Unpaid by Jul 21, 2027, it lapses early.
- 2 fees due Feb 22, 2027
- 3 fees due Mar 12 to 26, 2027 · next Mar 12
- 3 fees due May 12 to 21, 2027 · next May 12
- 2 fees due Jun 3 to 10, 2027 · next Jun 3
- 1 fee due Jul 9, 2027The maintenance fee for Spatially Encoded Biological Assays (US 11,866,770) comes due Jul 9, 2027. Unpaid by Jan 10, 2028, it lapses early.
- 1 fee due Aug 27, 2027The maintenance fee for Methods for Detecting Peptide/Mhc/Tcr Binding (US 11,913,952) comes due Aug 27, 2027. Unpaid by Feb 28, 2028, it lapses early.
- 2 fees due Oct 7 to 14, 2027 · next Oct 7
Recent changes
- 2 of the patents on this record were granted since Aug 23, 2026
What they patent
The largest of its 8 families, grouped by real patent family and labeled by the earliest filing in each. No technology classification is inferred from titles.
| Spatially Encoded Biological Assays | 46 in force | to May 2033 |
| Nucleic Acid Constructs and Methods of Use | 12 in force | to Apr 2031 |
| Methods and Systems for Determining Spatial Patterns of Biological Targets in a Sample | 9 in force | to Jun 2034 |
| Methods for Detecting Peptide/Mhc/Tcr Binding | 3 in force | to Mar 2034 |
| Peptide Constructs and Assay Systems | 2 in force | to Sep 2032 |
| Methods for Manufacturing Molecular Arrays | 2 in force | to Oct 2031 |
| Polynucleotide Conjugates and Methods for Analyte Detection | 1 in force | to Nov 2034 |
| Spatially Encoded Biological Assays Using a Microfluidic Device | 1 in force | to Jun 2034 |
Patents held now
Soonest term end first.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,783,847 | Nucleic Acid Constructs and Methods of Use In force · High confidence | In force | High confidence | |
| US 10,000,800 | Nucleic Acid Constructs and Methods of Use In force · High confidence | In force | High confidence | |
| US 10,119,165 | Nucleic Acid Constructs and Methods of Use In force · High confidence | In force | High confidence | |
| US 10,266,883 | Nucleic Acid Constructs and Methods of Use In force · High confidence | In force | High confidence | |
| US 10,266,884 | Nucleic Acid Constructs and Methods of Use In force · High confidence | In force | High confidence | |
| US 11,339,432 | Nucleic Acid Constructs and Methods of Use In force · High confidence | In force | High confidence | |
| US 11,352,665 | Nucleic Acid Constructs and Methods of Use In force · High confidence | In force | High confidence | |
| US 9,085,798 | Nucleic Acid Constructs and Methods of Use In force · High confidence | In force | High confidence | |
| US 10,501,793 | Nucleic Acid Constructs and Methods of Use In force · High confidence | In force | High confidence | |
| US 12,234,505 | Spatially Encoded Biological Assays In force · High confidence | In force | High confidence |
Also on record, not counted in the 76: 12 applications pending · 17 applications abandoned. List them
Sources and methods
Compiled from USPTO application file histories, grants and recorded assignments, with the company's own names reviewed by hand. How this record was built
Portfolio grouped automatically from ownership conveyances to the names matched to this company, usually every name that begins with its own, so it counts patents an affiliate holds; each list row names the holder of record. Security interests are excluded and ambiguous records are not reviewed by hand.
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.